Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

As Sickle Cell Gene Therapies Move To Market, Health Inequities Could Help Pricing Debate

11 Aug 2023

• By Cole Werble

gene and color background — • Source: Shutterstock

Related Content

US FDA AdComm For Vertex’s Sickle Cell Gene Therapy ‘Not A Concern’

02 Aug 2023

ICER Says Gene Therapies For Sickle Cell Likely To Improve Lives, But Points To Uncertainties

13 Apr 2023

Related Companies

Bluebird Bio

Vertex Pharmaceuticals Incorporated

CRISPR Therapeutics AG

Additional Topics

United States Gene Therapy Drug Review Pricing Debate Diversity & Inclusion Policy BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.